Conmed (CNMD) Tops Q4 EPS by 1c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
CONMED Corporation Announces Fourth Quarter and Full-Year 2018 Financial Results
January 22, 2019 4:01 PM ESTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights
Sales of $242.4 million increased 8.9% year over year as reported and 10.8% in constant currency and as adjusted(1). Domestic revenue increased 10.5% year over year as reported and 12.9% as adjusted(1). International revenue increased 7.3% as reported and 8.7% in constant currency. Diluted net earnings per share (GAAP) were $0.54, compared to... More


